- Home
- ATRA vs BLUE Comparison
ATRA vs BLUE Comparison
Compare ATRA & BLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- BLUE
- Stock Information
- Founded
- ATRA 2012
- BLUE 1992
- Country
- ATRA United States
- BLUE United States
- Employees
- ATRA N/A
- BLUE N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- BLUE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATRA Health Care
- BLUE Health Care
- Exchange
- ATRA Nasdaq
- BLUE Nasdaq
- Market Cap
- ATRA 39.7M
- BLUE 37.6M
- IPO Year
- ATRA 2014
- BLUE 2013
- Fundamental
- Price
- ATRA $6.86
- BLUE $3.73
- Analyst Decision
- ATRA Buy
- BLUE Hold
- Analyst Count
- ATRA 6
- BLUE 8
- Target Price
- ATRA $25.70
- BLUE $48.10
- AVG Volume (30 Days)
- ATRA 71.1K
- BLUE 566.9K
- Earning Date
- ATRA 03-07-2025
- BLUE 05-08-2025
- Dividend Yield
- ATRA N/A
- BLUE N/A
- EPS Growth
- ATRA N/A
- BLUE N/A
- EPS
- ATRA N/A
- BLUE N/A
- Revenue
- ATRA $128,940,000.00
- BLUE $53,120,000.00
- Revenue This Year
- ATRA N/A
- BLUE $145.10
- Revenue Next Year
- ATRA N/A
- BLUE $257.68
- P/E Ratio
- ATRA N/A
- BLUE N/A
- Revenue Growth
- ATRA 1404.02
- BLUE 144.50
- 52 Week Low
- ATRA $5.40
- BLUE $3.56
- 52 Week High
- ATRA $20.83
- BLUE $31.00
- Technical
- Relative Strength Index (RSI)
- ATRA 41.62
- BLUE 29.06
- Support Level
- ATRA $5.94
- BLUE $3.75
- Resistance Level
- ATRA $7.02
- BLUE $4.10
- Average True Range (ATR)
- ATRA 0.58
- BLUE 0.26
- MACD
- ATRA 0.07
- BLUE 0.05
- Stochastic Oscillator
- ATRA 52.36
- BLUE 29.31
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About BLUE bluebird bio Inc.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.